
Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell
2026-10-28 10:10:25Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 September 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 28 October 2026, providing investors with the latest perspective on the company’s position.
Read More
Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell
2026-10-16 10:10:25Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Biofil Chemicals & Pharmaceuticals Ltd is Rated Strong Sell
2026-09-29 10:10:18Biofil Chemicals & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 16 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Biofil Chemicals & Pharmaceuticals Ltd Downgraded to Sell Amid Mixed Technicals and Weak Fundamentals
2026-09-14 08:08:33Biofil Chemicals & Pharmaceuticals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 11 Sep 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap pharmaceutical company’s Mojo Score improved to 37.0, reflecting a more optimistic technical outlook, even as valuation and financial trends remain challenging.
Read More
Biofil Chemicals & Pharmaceuticals Ltd Locks at Upper Circuit With 19.58% Gain — Buyers Queue, Sellers Absent
2026-09-10 14:00:10At Rs 37.75, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Biofil Chemicals & Pharmaceuticals Ltd locked at its upper circuit of 19.58% on 10 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
16-Nov-2026 | Source : BSESubmission of publication of Un-audited financial results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Along With Limited Review Report.
14-Nov-2026 | Source : BSETo review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with limited review report
Board Meeting Outcome for Board Meeting Outcome To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2026 Along With Limited Review Report
14-Nov-2026 | Source : BSETo review consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with Limited Review Report.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available